The rate of hepatitis C virus (HCV) transmission from a woman with chronic HCV infection to her infant is approximately 5 percent; risk-based HCV screening of pregnant women is a standard recommendation in the United States. The American Association of the Study of Liver Disease (AASLD) and the Infectious Diseases Society of America (IDSA) recently updated their joint HCV guidelines to recommend screening all pregnant women, ideally at the initial prenatal visit. The rationale includes the limitations of risk-based screening, the increasing incidence of HCV among women of child-bearing age, and the potential to facilitate infant follow-up and postpartum HCV care for the mother.
Arguments against it include the likely low prevalence of HCV among pregnant women overall and the lack of interventions to prevent perinatal transmission. Some, but not all UpToDate contributors endorse the new recommendations; obstetric expert groups have not revised their screening approach.
For further more details please visit: https://gynecology.healthconferences.org/
No comments:
Post a Comment